Benralizumab reduces blood basophil percentage and activation in vitro without eliciting degranulation.
Allergy
; 2024 Jun 06.
Article
in En
| MEDLINE
| ID: mdl-38841822
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Allergy
Year:
2024
Document type:
Article
Affiliation country: